In severe obesity, subcutaneous adipose tissue cell-derived cytokines are early markers of impaired glucose tolerance and are modulated by quercetin.
Journal
International journal of obesity (2005)
ISSN: 1476-5497
Titre abrégé: Int J Obes (Lond)
Pays: England
ID NLM: 101256108
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
07
12
2020
accepted:
27
04
2021
revised:
19
04
2021
pubmed:
17
5
2021
medline:
29
1
2022
entrez:
16
5
2021
Statut:
ppublish
Résumé
Excessive adiposity provides an inflammatory environment. However, in people with severe obesity, how systemic and local adipose tissue (AT)-derived cytokines contribute to worsening glucose tolerance is not clear. Ninty-two severely obese (SO) individuals undergoing bariatric surgery were enrolled and subjected to detailed clinical phenotyping. Following an oral glucose tolerance test, participants were included in three groups, based on the presence of normal glucose tolerance (NGT), impaired glucose tolerance (IGT), or type 2 diabetes (T2D). Serum and subcutaneous AT (SAT) biopsies were obtained and mesenchymal stem cells (MSCs) were isolated, characterized, and differentiated in adipocytes in vitro. TNFA and PPARG mRNA levels were determined by qRT-PCR. Circulating, adipocyte- and MSC-released cytokines, chemokines, and growth factors were assessed by multiplex ELISA. Serum levels of IL-9, IL-13, and MIP-1β were increased in SO individuals with T2D, as compared with those with either IGT or NGT. At variance, SAT samples obtained from SO individuals with IGT displayed levels of TNFA which were threefold higher compared to those with NGT, but not different from those with T2D. Elevated levels of TNFα were also found in differentiated adipocytes, isolated from the SAT specimens of individuals with IGT and T2D, compared to those with NGT. Consistent with the pro-inflammatory milieu, IL-1β and IP-10 secretion was significantly higher in adipocytes from individuals with IGT and T2D. Moreover, increased levels of TNFα, both mRNA and secreted protein were detected in MSCs obtained from IGT and T2D, compared to NGT SO individuals. Exposure of T2D and IGT-derived MSCs to the anti-inflammatory flavonoid quercetin reduced TNFα levels and was paralleled by a significant decrease of the secretion of inflammatory cytokines. In severe obesity, enhanced SAT-derived inflammatory phenotype is an early step in the progression toward T2D and maybe, at least in part, attenuated by quercetin.
Sections du résumé
BACKGROUND
Excessive adiposity provides an inflammatory environment. However, in people with severe obesity, how systemic and local adipose tissue (AT)-derived cytokines contribute to worsening glucose tolerance is not clear.
METHODS
Ninty-two severely obese (SO) individuals undergoing bariatric surgery were enrolled and subjected to detailed clinical phenotyping. Following an oral glucose tolerance test, participants were included in three groups, based on the presence of normal glucose tolerance (NGT), impaired glucose tolerance (IGT), or type 2 diabetes (T2D). Serum and subcutaneous AT (SAT) biopsies were obtained and mesenchymal stem cells (MSCs) were isolated, characterized, and differentiated in adipocytes in vitro. TNFA and PPARG mRNA levels were determined by qRT-PCR. Circulating, adipocyte- and MSC-released cytokines, chemokines, and growth factors were assessed by multiplex ELISA.
RESULTS
Serum levels of IL-9, IL-13, and MIP-1β were increased in SO individuals with T2D, as compared with those with either IGT or NGT. At variance, SAT samples obtained from SO individuals with IGT displayed levels of TNFA which were threefold higher compared to those with NGT, but not different from those with T2D. Elevated levels of TNFα were also found in differentiated adipocytes, isolated from the SAT specimens of individuals with IGT and T2D, compared to those with NGT. Consistent with the pro-inflammatory milieu, IL-1β and IP-10 secretion was significantly higher in adipocytes from individuals with IGT and T2D. Moreover, increased levels of TNFα, both mRNA and secreted protein were detected in MSCs obtained from IGT and T2D, compared to NGT SO individuals. Exposure of T2D and IGT-derived MSCs to the anti-inflammatory flavonoid quercetin reduced TNFα levels and was paralleled by a significant decrease of the secretion of inflammatory cytokines.
CONCLUSION
In severe obesity, enhanced SAT-derived inflammatory phenotype is an early step in the progression toward T2D and maybe, at least in part, attenuated by quercetin.
Identifiants
pubmed: 33993191
doi: 10.1038/s41366-021-00850-1
pii: 10.1038/s41366-021-00850-1
doi:
Substances chimiques
Blood Glucose
0
Cytokines
0
Quercetin
9IKM0I5T1E
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1811-1820Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9(th) edition. Diab Res Clin Pract. 2019;157:107843.
doi: 10.1016/j.diabres.2019.107843
Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism. 2019;92:6–10.
pubmed: 30253139
doi: 10.1016/j.metabol.2018.09.005
Schernthaner G, Morton JM. Bariatric surgery in patients with morbid obesity and type 2 diabetes. Diabetes Care. 2008;31:S297–302.
pubmed: 18227500
doi: 10.2337/dc08-s270
Silveira EA, de Souza Rosa LP, de Carvalho Santos A, de Souza Cardoso CK, Noll M. Type 2 diabetes mellitus in class II and III obesity: prevalence, associated factors, and correlation between glycemic parameters and body mass index. Int J Environ Res Public Health. 2020;17:11.
D’Esposito V, Ambrosio MR, Giuliano M, Cabaro S, Miele C, Beguinot F, et al. Mammary adipose tissue control of breast cancer progression: impact of obesity and diabetes. Front Oncol. 2020;10:1554.
pubmed: 32850459
pmcid: 7426457
doi: 10.3389/fonc.2020.01554
Funcke JB, Scherer PE. Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication. J Lipid Res. 2019;60:1648–84.
pubmed: 31209153
pmcid: 6795086
doi: 10.1194/jlr.R094060
Poulos SP, Hausman DB, Hausman GJ. The development and endocrine functions of adipose tissue. Mol Cell Endocrinol. 2010;323:20–34.
pubmed: 20025936
doi: 10.1016/j.mce.2009.12.011
Smith U, Kahn BB. Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids. J Intern Med. 2016;280:465–75.
pubmed: 27699898
pmcid: 5218584
doi: 10.1111/joim.12540
Kusminski CM, Bickel PE, Scherer PE. Targeting adipose tissue in the treatment of obesity-associated diabetes. Nat Rev Drug Discov. 2016;15:639–60.
pubmed: 27256476
doi: 10.1038/nrd.2016.75
Hotamisligil GS, Spiegelman BM. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes. 1994;43:1271–8.
pubmed: 7926300
doi: 10.2337/diab.43.11.1271
Li D, Zhang T, Lu J, Peng C, Lin L. Natural constituents from food sources as therapeutic agents for obesity and metabolic diseases targeting adipose tissue inflammation. Crit Rev Food Sci Nutr. 2020: 1–19.
Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, et al. Quercetin, inflammation and immunity. Nutrients. 2016;8:167.
pubmed: 26999194
pmcid: 4808895
doi: 10.3390/nu8030167
Chen S, Jiang H, Wu X, Fang J. Therapeutic effects of quercetin on inflammation, obesity, and type 2 diabetes. Med Inflamm. 2016;2016:9340637.
Nettore IC, Rocca C, Mancino G, Albano L, Amelio D, Grande F, et al. Quercetin and its derivative Q2 modulate chromatin dynamics in adipogenesis and Q2 prevents obesity and metabolic disorders in rats. J Nutr Biochem. 2019;69:151–62.
pubmed: 31096072
doi: 10.1016/j.jnutbio.2019.03.019
Xu M, Pirtskhalava T, Farr JN, Weigand BM, Palmer AK, Weivoda MM, et al. Senolytics improve physical function and increase lifespan in old age. Nat Med. 2018;24:1246–56.
pubmed: 29988130
pmcid: 6082705
doi: 10.1038/s41591-018-0092-9
Eckel RH, Kahn SE, Ferrannini E, Goldfine AB, Nathan DM, Schwartz MW, et al. Obesity and type 2 diabetes: what can be unified and what needs to be individualized? Diabetes Care. 2011;34:1424–30.
pubmed: 21602431
pmcid: 3114323
doi: 10.2337/dc11-0447
Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C, et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol. 2019;10:1607.
pubmed: 32063863
doi: 10.3389/fphys.2019.01607
American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37:S81–90.
doi: 10.2337/dc14-S081
D’Esposito V, Lecce M, Marenzi G, Cabaro S, Ambrosio MR, Sammartino G, et al. Platelet-rich plasma counteracts detrimental effect of high-glucose concentrations on mesenchymal stem cells from Bichat fat pad. J Tissue Eng Regener Med. 2020;14:701–13.
doi: 10.1002/term.3032
de Girolamo L, Lucarelli E, Alessandri G, Avanzini MA, Bernardo ME, Biagi E, et al. Mesenchymal stem/stromal cells: a new “cells as drugs” paradigm. Efficacy and critical aspects in cell therapy. Curr Pharmaceut Des. 2013;19:2459–73.
doi: 10.2174/1381612811319130015
Aprile M, Ambrosio MR, D’Esposito V, Beguinot F, Formisano P, Costa V, et al. PPARG in human adipogenesis: differential contribution of canonical transcripts and dominant negative isoforms. PPAR Res. 2014;2014:537865.
pubmed: 24790595
pmcid: 3981527
doi: 10.1155/2014/537865
Caso F, Postiglione L, Covelli B, Ricciardone M, Di Spigna G, Formisano P, et al. Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset “sine psoriasis”. Clin Rheumatol. 2019;38:2547–52.
pubmed: 31147798
doi: 10.1007/s10067-019-04619-w
Pisano S, Catone G, Coppola G, Carotenuto M, Iuliano R, Tiano C, et al. Different immune signature in youths experiencing antipsychotic-induced weight gain compared to untreated obese patients. J Child Adolesc Psychopharmacol. 2017;27:844–8.
pubmed: 28453334
doi: 10.1089/cap.2016.0203
Ambrosio MR, D’Esposito V, Costa V, Liguoro D, Collina F, Cantile M, et al. Glucose impairs tamoxifen responsiveness modulating connective tissue growth factor in breast cancer cells. Oncotarget. 2017;8:109000–17.
pubmed: 29312586
pmcid: 5752499
doi: 10.18632/oncotarget.22552
Vinciguerra F, Baratta R, Farina MG, Tita P, Padova G, Vigneri R, et al. Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease. Acta Diabetol. 2013;50:443–9.
pubmed: 23447004
doi: 10.1007/s00592-013-0460-3
Catoi AF, Busetto L. Metabolically healthy obesity and bariatric surgery. Obes Surg. 2019;29:2989–3000.
pubmed: 31273650
doi: 10.1007/s11695-019-03964-8
Dalmas E, Rouault C, Abdennour M, Rovere C, Rizkalla S, Bar-Hen A, et al. Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction. Am J Clin Nutr. 2011;94:450–8.
pubmed: 21677057
doi: 10.3945/ajcn.111.013771
Schmidt FM, Weschenfelder J, Sander C, Minkwitz J, Thormann J, Chittka T, et al. Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLoS ONE. 2015;10:e0121971.
pubmed: 25781614
pmcid: 4363366
doi: 10.1371/journal.pone.0121971
van der Zalm IJB, van der Valk ES, Wester VL, Nagtzaam NMA, van Rossum EFC, Leenen PJM, et al. Obesity-associated T-cell and macrophage activation improve partly after a lifestyle intervention. Int J Obes. 2020;44:1838–50.
doi: 10.1038/s41366-020-0615-6
Chakraborty S, Kubatzky KF, Mitra DK. An update on interleukin-9: from its cellular source and signal transduction to its role in immunopathogenesis. Int J Mol Sci. 2019;20:9.
doi: 10.3390/ijms20092113
Stechova K, Halbhuber Z, Hubackova M, Kayserova J, Petruzelkova L, Vcelakova J, et al. Case report: type 1 diabetes in monozygotic quadruplets. Eur J Hum Genet. 2012;20:457–62.
pubmed: 22108602
doi: 10.1038/ejhg.2011.212
Chang TT, Chen JW. Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes? Cardiovasc Diabetol. 2016;15:117.
pubmed: 27553774
pmcid: 4995753
doi: 10.1186/s12933-016-0439-9
Jiang LQ, Franck N, Egan B, Sjogren RJ, Katayama M, Duque-Guimaraes D, et al. Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7. Am J Physiol Endocrinol Metab. 2013;305:E1359–66.
pubmed: 24105413
doi: 10.1152/ajpendo.00236.2013
Parisi V, Cabaro S, D’Esposito V, Petraglia L, Conte M, Campana P, et al. Epicardial adipose tissue and IL-13 response to myocardial injury drives left ventricular remodeling after ST elevation myocardial infarction. Front Physiol. 2020;11:575181.
pubmed: 33178043
pmcid: 7593695
doi: 10.3389/fphys.2020.575181
Chen H, Wen F, Zhang X, Su SB. Expression of T-helper-associated cytokines in patients with type 2 diabetes mellitus with retinopathy. Mol Vis. 2012;18:219–26.
pubmed: 22312190
pmcid: 3272054
Crewe C, An YA, Scherer PE. The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis. J Clin Investig. 2017;127:74–82.
pubmed: 28045400
pmcid: 5199684
doi: 10.1172/JCI88883
Bullo M, Garcia-Lorda P, Peinado-Onsurbe J, Hernandez M, Del Castillo D, Argiles JM, et al. TNFalpha expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis. Int J Obesity Relat Metab Disord. 2002;26:652–8.
doi: 10.1038/sj.ijo.0801977
Hoffstedt J, Arner E, Wahrenberg H, Andersson DP, Qvisth V, Lofgren P, et al. Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity. Diabetologia. 2010;53:2496–503.
pubmed: 20830466
doi: 10.1007/s00125-010-1889-3
Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ito K, et al. Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1998;83:859–62.
pubmed: 9506740
Febbraio MA. Role of interleukins in obesity: implications for metabolic disease. Trends Endocrinol Metab. 2014;25:312–9.
pubmed: 24698032
doi: 10.1016/j.tem.2014.02.004
Narumi S, Yoneyama H, Inadera H, Nishioji K, Itoh Y, Okanoue T, et al. TNF-alpha is a potent inducer for IFN-inducible protein-10 in hepatocytes and unaffected by GM-CSF in vivo, in contrast to IL-1beta and IFN-gamma. Cytokine. 2000;12:1007–16.
pubmed: 10880246
doi: 10.1006/cyto.1999.0672
Parisi V, Petraglia L, Cabaro S, D’Esposito V, Bruzzese D, Ferraro G, et al. Imbalance between interleukin-1beta and interleukin-1 receptor antagonist in epicardial adipose tissue is associated with non ST-segment elevation acute coronary syndrome. Front Physiol. 2020;11:42.
pubmed: 32116755
pmcid: 7012938
doi: 10.3389/fphys.2020.00042
Hueso L, Ortega R, Selles F, Wu-Xiong NY, Ortega J, Civera M, et al. Upregulation of angiostatic chemokines IP-10/CXCL10 and I-TAC/CXCL11 in human obesity and their implication for adipose tissue angiogenesis. Int J Obes. 2018;42:1406–17.
doi: 10.1038/s41366-018-0102-5
Ejarque M, Ceperuelo-Mallafre V, Serena C, Maymo-Masip E, Duran X, Diaz-Ramos A, et al. Adipose tissue mitochondrial dysfunction in human obesity is linked to a specific DNA methylation signature in adipose-derived stem cells. Int J Obes. 2019;43:1256–68.
doi: 10.1038/s41366-018-0219-6
Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA, et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci. 2019;20:9.
doi: 10.3390/ijms20092358
Aprile M, Cataldi S, Ambrosio MR, D’Esposito V, Lim K, Dietrich A, et al. PPARγΔ5, a naturally occurring dominant-negative splice isoform, impairs PPARγ function and adipocyte differentiation. Cell Rep. 2018;25:1577–92 e6.
pubmed: 30404011
doi: 10.1016/j.celrep.2018.10.035
Aprile M, Cataldi S, Perfetto C, Ambrosio MR, Italiani P, Tate R. et al. In-vitro-generated hypertrophic-like adipocytes displaying PPARG isoforms unbalance recapitulate adipocyte dysfunctions in vivo. Cells. 2020;9:5
doi: 10.3390/cells9051284
D’Esposito V, Passaretti F, Hammarstedt A, Liguoro D, Terracciano D, Molea G, et al. Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro. Diabetologia. 2012;55:2811–22.
pubmed: 22798065
pmcid: 3433668
doi: 10.1007/s00125-012-2629-7
Ronningen T, Shah A, Reiner AH, Collas P, Moskaug JO. Epigenetic priming of inflammatory response genes by high glucose in adipose progenitor cells. Biochem Biophys Res Commun. 2015;467:979–86.
pubmed: 26462465
doi: 10.1016/j.bbrc.2015.10.030
Raciti GA, Spinelli R, Desiderio A, Longo M, Parrillo L, Nigro C, et al. Specific CpG hyper-methylation leads to Ankrd26 gene down-regulation in white adipose tissue of a mouse model of diet-induced obesity. Sci Rep. 2017;7:43526.
pubmed: 28266632
pmcid: 5339897
doi: 10.1038/srep43526
Gowers IR, Walters K, Kiss-Toth E, Read RC, Duff GW, Wilson AG. Age-related loss of CpG methylation in the tumour necrosis factor promoter. Cytokine. 2011;56:792–7.
pubmed: 22004920
doi: 10.1016/j.cyto.2011.09.009
Rancourt RC, Ott R, Ziska T, Schellong K, Melchior K, Henrich W, et al. Visceral adipose tissue inflammatory factors (TNF-Alpha, SOCS3) in gestational diabetes (GDM): epigenetics as a clue in GDM pathophysiology. Int J Mol Sci. 2020;21:2.
doi: 10.3390/ijms21020479
Palmer AK, Xu M, Zhu Y, Pirtskhalava T, Weivoda MM, Hachfeld CM, et al. Targeting senescent cells alleviates obesity-induced metabolic dysfunction. Aging Cell. 2019;18:e12950.
pubmed: 30907060
pmcid: 6516193
doi: 10.1111/acel.12950
Lee Y, Song YS, Fang CH, So BI, Park JY, Joo HW, et al. Anti-obesity effects of granulocyte-colony stimulating factor in Otsuka-Long-Evans-Tokushima fatty rats. PLoS ONE. 2014;9:e105603.
pubmed: 25144367
pmcid: 4140798
doi: 10.1371/journal.pone.0105603
Spoto B, Di Betta E, Mattace-Raso F, Sijbrands E, Vilardi A, Parlongo RM, et al. Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity. Nutr Metab Cardiovasc Dis. 2014;24:1137–43.
pubmed: 24984824
doi: 10.1016/j.numecd.2014.04.017